Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
John J. NicolsPresident & CEO932,4992.35%2015-03-05
Mr. Douglas T. SheehySVP, General Counsel & Sec.231,2050.58%2015-03-05
Dr. Patrick Y. Yang, PhDN/A229,5150.58%2014-11-18
James LalondeSVP, R&D163,9390.41%2015-03-05
Bernard KelleyDirector160,9490.41%2014-06-11
Thomas R. BaruchDirector138,4510.35%2014-06-11
Mr. Byron L. DorganN/A135,9510.34%2014-06-11
Mr. Dennis P. WolfN/A135,9510.34%2014-06-11
Mr. David D. O'TooleSVP & CFO110,6870.28%2013-09-04
Dr. David L. AntonSVP, BioIndustrials93,7770.24%2013-02-10

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Yang Patrick YDirector2014-11-18Buy20,000229,515$2.354770.64Link
Yang Patrick YDirector2014-11-17Buy20,000209,515$2.3446.871.37Link
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner2014-11-10Sell2,921,2250$2.376923.369.2Link
Yang Patrick YDirector2014-08-12Buy60,000189,515$2.22133.280.63Link
NICOLS JOHN JPresident & CEO
(Click for the stocks that their CEOs have bought)
2013-03-08Buy27,000911,000$2.4265.365.7Link
NICOLS JOHN JPresident & CEO2013-03-07Buy54,000884,000$2.22119.980.63Link
O'Toole David DSVP & CFO2013-03-04Buy10,000115,384$2.0220.298.51Link
O'Toole David DSVP & CFO2012-11-12Buy5,00060,000$2.21182.27Link
O'Toole David DSVP & CFO2012-09-14Buy5,00055,000$2.7813.944.24Link
Sheehy Douglas T.SVP, General Counsel & Sec.2012-09-14Sell3,80069,200$2.7610.545.29Link
Anton David L.SVP, BioIndustrials2012-09-14Sell3,80070,200$2.7610.545.29Link
SHAW ALANPresident and CEO2011-12-16Sell53,846277,000$5.28284.3-24.05Link
SHAW ALANPresident and CEO2011-12-14Sell37,820330,846$5.27199.3-23.91Link
SHAW ALANPresident and CEO2011-07-07Sell15,000368,666$10.13152-60.41Link
SHAW ALANPresident and CEO2011-06-02Sell15,000368,666$10.39155.9-61.41Link
Lawson Robert JSVP and CFO2011-05-11Buy2,00044,000$9.519-57.79Link
SHAW ALANPresident and CEO2011-05-02Sell15,000268,666$10.44156.6-61.59Link
SHAW ALANPresident and CEO2011-04-01Sell15,000268,666$12.07181.1-66.78Link
SHAW ALANPresident and CEO2011-03-01Sell15,000218,666$10.65159.8-62.35Link
SHAW ALANPresident and CEO2011-02-11Sell15,000218,666$10.46156.9-61.66Link
BARUCH THOMAS RDirector2010-08-27Buy2,5002,742,658$7.5518.9-46.89Link
Pasternack Bruce ADirector2010-08-24Buy10,00010,000$7.7877.8-48.46Link
SHAW ALANPresident and CEO2010-08-10Buy2,00096,132$816-49.88Link
Sheehy Douglas T.SVP, Gen Counsel and Sec.2010-08-10Buy1,0001,000$7.998-49.81Link
Sarret Joseph J.CBO, President Pharmaceuticals2010-08-10Buy2,00015,333$7.9916-49.81Link
Lawson Robert JSVP and CFO2010-08-10Buy2,0002,000$816-49.88Link
Anton David L.SVP, Research and Development2010-08-10Buy2,0002,000$7.9916-49.81Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK